Apparent mineralocorticoid excess
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
23
|
15
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
11-Beta-Hydroxysteroid Dehydrogenase Type 1 Deficiency
|
disease |
|
Disease or Syndrome
|
1
|
|
0.200 |
None |
1.000 |
6 |
|
1997 |
2004 |
CORTISONE REDUCTASE DEFICIENCY 2
|
disease |
|
Disease or Syndrome
|
2
|
1
|
0.300 |
None |
1.000 |
6 |
1
|
1997 |
2004 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.380 |
None |
1.000 |
11 |
2
|
1998 |
2017 |
Chronic kidney disease stage 5
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
666
|
194
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Kidney Failure, Chronic
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
827
|
425
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Mineralocorticoid Excess Syndrome, Apparent
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
8
|
1
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.600 |
None |
0.970 |
33 |
5
|
2002 |
2019 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.060 |
None |
0.833 |
6 |
1
|
2002 |
2018 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.060 |
None |
0.833 |
6 |
1
|
2002 |
2018 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1183
|
103
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2003 |
Cone-Rod Dystrophy 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
254
|
51
|
0.070 |
None |
1.000 |
7 |
1
|
2003 |
2013 |
Osteoporosis
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
1098
|
182
|
0.040 |
None |
1.000 |
4 |
|
2003 |
2013 |
Adrenal Gland Neoplasms
|
group |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
94
|
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2011 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.300 |
None |
0.857 |
28 |
5
|
2004 |
2019 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.300 |
None |
0.905 |
21 |
3
|
2004 |
2019 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.080 |
None |
1.000 |
8 |
1
|
2004 |
2019 |
Obesity, Visceral
|
phenotype |
Nutritional and Metabolic Diseases
|
Sign or Symptom
|
55
|
3
|
0.330 |
None |
1.000 |
4 |
|
2004 |
2019 |
Hyperglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1098
|
108
|
0.310 |
None |
1.000 |
2 |
|
2004 |
2017 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hyperglycemia, Postprandial
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
37
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hyperlipidemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
472
|
83
|
0.200 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hyperlipoproteinemias
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
49
|
7
|
0.200 |
None |
1.000 |
1 |
|
2004 |
2004 |
Obesity, Abdominal
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |